Hayashi M, Sasaki S, Tsuganezawa H, Monkawa T, Kitajima W, Konishi K, Fushimi K, Marumo F, Saruta T
Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan.
Kidney Blood Press Res. 1996;19(1):32-7. doi: 10.1159/000174043.
Aquaporin-2 (AQP-2) has been shown to be a vasopressin-sensitive water channel in collecting duct (CD) cells of the kidney. To prove the role of the vasopressin V2 receptor (V2R) in the regulation of intracellular AQP-2 shuttling, we examined the acute effects of vasopressin and V2R antagonist on the distribution of AQP-2 in the cells. Normal Wistar rats were given continuous infusions of vasopressin, vasopressin V2R antagonist (OPC31260), or both. The kidneys were then processed for immunofluorescent studies with an affinity-purified specific antibody to AQP-2. One hour after the infusion of the V2R antagonist, AQP-2 staining was diffusely distributed in the CD cells from the cortex to the inner medulla. This tendency was not changed by the concomitant infusion with vasopressin. Vasopressin infusion without antagonist, however, induced intensified AQP-2 staining of the apical membrane in the CD cells. The ratio of the fluorescence intensity of the apical to subapical region was determined by confocal laser microscopy. In the inner medulla, this ratio was significantly increased in the vasopressin treatment group (2.26 +/- 0.76) as compared to the V2R antagonist group (1.03 +/- 0.34) and the combined treatment group (0.84 +/- 0.43). The increase in the ratio was also demonstrated in the cortex and the outer medulla in the vasopressin-treated group. In addition, Northern blotting studies clearly revealed that mRNA of AQP-2 in the vasopressin-treated group was increased when compared to the combined treatment animals. Our present results reveal that localization and gene expressions of AQP-2 are acutely regulated via vasopressin V2R.
水通道蛋白-2(AQP-2)已被证明是肾脏集合管(CD)细胞中一种对血管加压素敏感的水通道。为了证明血管加压素V2受体(V2R)在调节细胞内AQP-2穿梭中的作用,我们研究了血管加压素和V2R拮抗剂对细胞内AQP-2分布的急性影响。给正常的Wistar大鼠持续输注血管加压素、血管加压素V2R拮抗剂(OPC31260)或两者。然后用针对AQP-2的亲和纯化特异性抗体对肾脏进行免疫荧光研究。输注V2R拮抗剂1小时后,AQP-2染色从皮质到髓质内的CD细胞中呈弥漫性分布。同时输注血管加压素并没有改变这种趋势。然而,在没有拮抗剂的情况下输注血管加压素,可诱导CD细胞顶端膜上的AQP-2染色增强。通过共聚焦激光显微镜测定顶端区域与顶端下区域的荧光强度比值。在髓质内,血管加压素治疗组的该比值(2.26±0.76)与V2R拮抗剂组(1.03±0.34)和联合治疗组(0.84±0.43)相比显著增加。在血管加压素治疗组的皮质和外髓质中也显示出该比值的增加。此外,Northern印迹研究清楚地表明,与联合治疗的动物相比,血管加压素治疗组中AQP-2的mRNA增加。我们目前的结果表明,AQP-2的定位和基因表达通过血管加压素V2R受到急性调节。